Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
11/2010
11/30/2010CA2460682C Ester compound and medical use thereof
11/25/2010WO2010134014A1 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
11/25/2010WO2010133748A1 Protease inhibitors
11/25/2010WO2010133337A1 Herbicidal spiroheterocyclic tetronic acid derivatives
11/25/2010US20100298567 Nitration of activated aromatics in microreactors
11/25/2010US20100298347 Substituted 2-naphthoic acids as antagonists of gpr105 activity
11/25/2010US20100298341 Glycine Transporter-1 Inhibitors
11/25/2010US20100298329 Tolperisone and tolperisone-like drugs for the treatment of k-ras associated cancers
11/25/2010US20100298328 1-Heterocyclylamino-2-Hydroxy-3-Amino-Omega-Arylalkanes
11/25/2010US20100298278 Inhibitors of beta-secretase for the treatment of alzheimer's disease
11/25/2010US20100298168 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
11/25/2010US20100297077 Novel aryl potassium channel blockers and uses thereof
11/25/2010CA2760885A1 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
11/25/2010CA2758222A1 Protease inhibitors
11/24/2010EP2253620A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
11/24/2010EP2253615A1 Cyclopropyl amide derivatives
11/24/2010EP2253315A1 Alkoxyphenylpropanoic acid derivatives
11/24/2010EP2252587A1 Piperidine sulfonamide derivatives
11/24/2010EP2252149A2 A method for the preparation of fentanyl
11/24/2010EP1973878B1 Process and intermediate for preparation of donepezil
11/24/2010EP1939178B1 Process for producing 1-benzyl-4-[(5,6-dimethoxy-1indanon)-2-yl]methylpiperidine or hydrochloride thereof
11/24/2010EP1583972B1 Methods for identifying drug non-target proteins
11/24/2010CN101896584A Cycloalkyl phenylenediamines as deposit control agents for lubricants
11/24/2010CN101896459A Anthelmintic agents and their use
11/24/2010CN101891672A Separation and purification method and device for extracting and purifying piperidinol product from piperidone hydrogenation reaction solution
11/24/2010CN101890166A Combination of organic compounds
11/23/2010CA2459380C Reverse hydroxamic acid derivatives
11/23/2010CA2438870C Novel inhibitors of formation of advanced glycation endproducts (ages)
11/23/2010CA2433585C Pharmaceutical compositions containing donepezil hydrochloride
11/18/2010WO2010132671A1 Treatment of mci and alzheimer's disease
11/18/2010WO2010130638A1 Sulfonamide compounds, pharmaceutical compositions and uses thereof
11/18/2010WO2010004269A3 Stereospecific synthesis of iduronic acid derivatives, deoxynojirimycin and deoxyidonojirimycin
11/18/2010US20100292500 Npy y5 antagonist
11/18/2010US20100292467 Low molecular weight quaternary ammonium salt dispersants
11/18/2010US20100292439 Use of Functionalized Onium Salts for Peptide Synthesis
11/18/2010US20100292436 Method for producing bivalirudin
11/18/2010US20100292252 Vinyl-aryl derivatives for inflammation and immune-related uses
11/18/2010US20100292229 Tryphostin-analogs for the treatment of cell proliferative diseases
11/18/2010US20100292225 Aryl pyridine as aldosterone synthase inhibitors
11/18/2010US20100292215 11beta-hydroxysteroid dehydrogenase type 1 active compounds
11/18/2010US20100292206 Heterocyclic compound
11/18/2010US20100291299 Strontium and barium precursors for use in chemical vapor deposition, atomic layer deposition and rapid vapor deposition
11/18/2010US20100291026 Piperidine inhibitors of janus kinase 3
11/18/2010CA2761298A1 Treatment of mci and alzheimer's disease
11/17/2010EP2046743B1 Process for preparing fexofenadine
11/17/2010EP1797035B1 Cyclopropyl piperidine glycine transporter inhibitors
11/17/2010EP1791815B1 Pyrrolidine derivatives acting as ccr3-receptor antagonists
11/17/2010EP1778671B1 Piperazine derivatives with ccr3 inhibiting activity
11/17/2010EP1032377B1 Substituted 2-aminoacetamides and the use thereof
11/17/2010CN101888989A Novel aryl potassium channel blockers and uses thereof
11/17/2010CN101885701A Hindered amine compound having double-hindered phenol structure for light stabilizer and preparation method thereof
11/16/2010US7834185 Chronic obstructive pulmonary diseases; asthma
11/16/2010US7834182 histamine H3 receptor antagonists; metabolic disorders, sleep disorders, cardiovascular disorders, alcoholism, drug addiction, memory disorders, Alzheimer's, Parkinson's disease; 2-(4-piperidinylpiperidinyl)pyrimidine compounds such as 2-[(4-piperidin-1-yl)piperidin-1-yl]-5-(3-pyridyl)pyrimidine
11/16/2010US7834054 Hydroxamates as therapeutic agents
11/16/2010US7834047 Arylsulfonamides and uses related thereto
11/16/2010US7834035 Allosteric modulators of metabotropic glutamate receptors
11/16/2010US7834031 18F, 11C, or deuterated fluoromethoxy-substituted 4-phenyl-4-benzoylaminomethylpiperindosulfonyl compounds for diagnostic imaging
11/16/2010US7834012 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
11/16/2010US7834010 gastrointestinal disorders, urinary tract disorders such as hyperactive bladder, and cardiovascular disorders without side effects related to CNS activity; acid moiety makes drug unable to cross the blood-brain barrier; carboxy, phosphonic, sulfonic, or phosphoric acid derivative of piboserod (DDL-6001)
11/16/2010US7834008 neurokinin receptor 3 (NK3) antagonists; psychological disorders, inflammatory bowel disease, asthma, ischemia, Parkinson's disease; e.g. (1S,2R)-2-(4-Acetylamino-4-phenyl-piperidin-1-ylmethyl)-1-(3,4-dichlorophenyl)-cyclopropanecarboxylic acid, benzyl-methyl-amide
11/16/2010US7833997 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability
11/16/2010US7833540 methoxycinnamate compounds; hypoallergenic sunscreens; bioavailability, shelf life
11/11/2010WO2010128528A2 Novel heterocyclic compounds
11/11/2010WO2010128102A1 Carboxamide compounds and their use as calpain inhibitors
11/11/2010WO2010096371A3 Heterocyclic compounds which modulate the cb2 receptor
11/11/2010US20100286401 for selective hydrogenation of aldehydes, ketones and imines; a catalyst such as dicarbonyl iron hydride hydroxycyclopentadiene) complex uses the OH on the five member ring and hydrogen linked to the iron to facilitate hydrogenation reactions, particularly in the presence of hydrogen gas
11/11/2010US20100286399 Process for the preparation of an n-alkyl lactam with improved colour quality
11/11/2010US20100286207 Novel 2-Oxo-Heterocyclic Compounds And The Pharmaceutical Compositions Comprising The Same
11/11/2010US20100286204 Compound capable of inhibiting 17-beta hydroxysteriod dehydrogenase
11/11/2010US20100286197 Carboxamide Derivatives As Therapeutic Agents
11/11/2010US20100286182 Hydrazide compounds as thyroid hormone receptor modulators and uses thereof
11/11/2010US20100286162 Human papilloma virus inhibitors and pharmaceutical compositions containing same
11/11/2010US20100286152 N-phenyl hydrazides as modulators of the ghrelin receptor
11/11/2010US20100286146 Carboxamide compounds and their use as calpain inhibitors
11/11/2010US20100286132 Pyridines
11/11/2010US20100286125 Hydroxamic acid derivatives of 4-phenyl 4-hydroxy, 4-phenyl 4-alkoxy and 4-phenyl 4-arylalkoxy butyric acid useful as therapeutic agents for treating anthrax poisoning
11/11/2010US20100286109 Amide derivatives as positive allosteric modulators and methods of use thereof
11/11/2010US20100282081 Absorbent liquid, and apparatus and method for removing c02 or h2s from gas with use of absorbent liquid
11/11/2010CA2764232A1 Novel heterocyclic compounds
11/11/2010CA2761241A1 Tetracycline compounds
11/11/2010CA2760464A1 Carboxamide compounds and their use as calpain inhibitors
11/11/2010CA2758302A1 Compounds and compositions comprising cdk inhibitors and methods for treatment of cancer
11/10/2010EP2248803A1 Method for optical resolution of alkylpiperidin-3-yl carbamate and intermediate therefor
11/10/2010CN1980889B Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/10/2010CN101880277A Aza spiro alkane derivatives as inhibitors of metallproteases
11/10/2010CN101880257A Method for synthesizing all-cis Tilmicosin
11/10/2010CN101879457A Novel nano-solid strong base catalyst, preparation method thereof and application thereof
11/10/2010CN101879444A Preparation and application of stannate solid alkali catalyst
11/10/2010CN101209990B Resolution method for 3-piperidine formic acid ester
11/09/2010US7829712 Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase
11/09/2010US7829583 Biphenyl derivatives
11/09/2010US7829582 hydroxysteroid reductase inhibitors such as 4-{(R)-3-[3,5-Dichloro-4'-(4-trifluoromethyl-piperidine-1-carbonyl)-biphenyl-4-ylmethyl]-2-oxo-pyrrolidin-1-yl}-piperidine-1-carboxylic acid methyl ester, used for treating diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia and metabolic syndrome
11/09/2010US7829580 Cyclic amine derivative having heteroaryl ring
11/09/2010US7829579 Method for the treatment of neurological disorders by enhancing the activity of β-glucocerebrosidase
11/09/2010US7829571 monocyte chemotactic protein antagonists such as -(3S)-1-(4-(tert-butylamino)cyclohexyl)-3-(6-(trifluoromethyl)quinazolin-4-ylamino)pyrrolidin-2-one, used for the treatment of asthma, multiple sclerosis, arteriosclerosis and rheumatoid arthritis
11/09/2010US7829565 such as 5-{4-[4-(5-cyano-2,3-dihydro-1H-indol-3-yl)butyl]piperazin-1-yl}benzo-furan-2-carboxamide, used as antidepressant, anxiolytic, neuroleptic and/or hyportensive agents and for treating headaches, tardive dyskinesia, obsessive compulsive, sleep, eating, sexual and/or learning disorders
11/09/2010US7829564 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/09/2010US7829560 such as N-(4-{[2-(4-Ethylpiperazin-1-yl)pyrimidin-4-yl]oxy}-1-naphthyl)-3-fluoro-5-piperidin-1-ylbenzamide, useful as antiproliferative agents or in treating arthritis, osteoarthritis, Crohn's disease, ulcerative colitis, inflammatory bowel disease, psoriasis, autoimmune or inflammatory diseases
11/09/2010CA2520297C Mass labels
11/09/2010CA2434937C Phenyl derivatives
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 380